Transfusion Medicine

Thermogenesis inks European distribution agreement for fibrin sealant system

Published in TB and Outbreaks Week, April 2nd, 2002

Thermogenesis Corp. (KOOL) today announced that it has signed a distribution agreement with Dideco, S.p.A., in Mirandola, Italy to begin immediate commercialization of its CryoSeal Fibrin Sealant (FS) System in Europe, Eastern Europe, portions of Scandinavia and the Middle East, and Africa.

The new system radically reduces Mad Cow disease concerns by providing a fibrin sealant sourced from either the patient's own blood or from a single donor without any bovine additive. The company believes the annualized worldwide market for fibrin sealant is approximately $500 million, of which $100 million is consumed by Europe alone.

According to Mario...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2002-04-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry